Waters developed the kit with a coalition of academic, commercial, and government research scientists to create an alternative test method on LC-MS platforms in support of the U.K.'s National Health Service (NHS) Test & Trace program. Waters and team sought to create a complementary, high-throughput screening method that would also use different reagents to help relieve strain on the polymerase chain reaction (PCR) reagent supply chain.

The kit is available for use on the Acquity I-Class Plus System and Xevo TQ-XS System. It comes with an adaptable, automation-friendly format for liquid handling protocols using the Andrew+ Pipetting Robot on OneLab Software, according to Waters.

Sample results can be taken with clean, low-noise chromatograms in less than two minutes per sample, Waters said. Furthermore, the kit can be used for peptide concentration studies and research regarding the long-term effects of infection through peptide quantitation.

Future pandemic preparedness studies and research of signature peptide-based biomarkers may support gathering information about other infections, Waters added.

Waters' SARS-CoV-2 LC-MS Kit. Image courtesy of Waters.

Sciex, Waters collaborate to offer fully integrated LC-MS systems
Sciex and Waters have inked a deal to provide integrated liquid chromatography and mass spectrometry (LC-MC) systems.

Waters reports 30% sales increase in Q1
Lab equipment supplier Waters reported significant sales growth during the first quarter of 2021.

Waters taps new executives
Lab equipment supplier Waters has announced several leadership appointments and retirements.

Waters, Genovis team up on automated CQA characterization
Waters and Genovis are working together to develop and market routine biopharmaceutical characterization workflows of critical quality attributes (CQAs)...

Waters launches MAM workflow for protein-based drug analysis
Waters has introduced a new peptide multiattribute method (MAM) workflow for its BioAccord liquid chromatography-mass spectrometry system.